Travere Therapeutics (TVTX) Share-based Compensation Growth (5y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Travere Therapeutics | 4.14 Bn | 4.06 Bn | 102.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.35% |
| Dec 31, 2025 | 10.37% |
| Sep 30, 2025 | 16.99% |
| Jun 30, 2025 | 13.86% |
| Mar 31, 2025 | 14.23% |
| Dec 31, 2024 | 12.99% |
| Sep 30, 2024 | 14.07% |
| Jun 30, 2024 | 11.81% |
| Mar 31, 2024 | 9.25% |
| Dec 31, 2023 | 10.90% |
| Sep 30, 2023 | 18.92% |
| Jun 30, 2023 | 15.51% |
| Mar 31, 2023 | 23.66% |
| Dec 31, 2022 | 10.74% |
| Sep 30, 2022 | 2.88% |
| Jun 30, 2022 | 11.79% |
| Mar 31, 2022 | 2.91% |
| Dec 31, 2021 | 0.86% |
| Sep 30, 2021 | -2.05% |
| Jun 30, 2021 | -0.53% |
| Mar 31, 2021 | 3.09% |
| Dec 31, 2020 | -0.43% |
| Sep 30, 2020 | -8.88% |
| Jun 30, 2020 | 2.19% |
| Mar 31, 2020 | 1.18% |
| Dec 31, 2019 | -5.57% |
| Sep 30, 2019 | 5.36% |
| Jun 30, 2019 | 16.65% |
| Mar 31, 2019 | 12.99% |
| Dec 31, 2018 | -2.01% |
| Sep 30, 2018 | 178.29% |
| Mar 31, 2018 | 195.06% |